Oxford Asset Management »

Abcellera Biologics shares owned by Oxford Asset Management

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Oxford Asset Management from 13F filings

Historical chart of Oxford Asset Management investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Oxford Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Oxford Asset Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $63k 28k 2.23

More positions owned by Oxford Asset Management

Spdr Series Trust S&p Biotech (XBI)
Snap Note 0.125% 3/0
Freeport-mcmoran CL B (FCX)
Dropbox Note 3/0
General Mills (GIS)
Ford Motor Company (F)
Comcast Corp Cl A (CMCSA)
Citigroup Com New (C)
Ferguson Enterprises Common Stock New (FERG)
Nike CL B (NKE)
Amazon (AMZN)
Boeing Company (BA)
EOG Resources (EOG)
Pfizer (PFE)
Meridianlink Common Stock (MLNK)

View all positions for Oxford Asset Management

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Capital World Investors
Baillie Gifford & Co
Two Sigma Investments
Two Sigma Advisers
Arrowpoint Asset Management
BlackRock
Renaissance Technologies
Tang Capital Management
UBS Group
Millennium Management
Susquehanna International
Guardian Partners
Driehaus Capital Management
Citadel Advisors

View all funds holding Abcellera Biologics